StreetInsider.com After-Hours Movers 04/12
Shares of Dyax Corp. (Nasdaq: DYAX) 44% HIGHER; announced positive topline results from its Phase 3, placebo-controlled trial, EDEMA3, for its lead product candidate DX-88 (ecallantide), for hereditary angioedema (HAE). Statistically significant results were achieved for both the primary and…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Shares of Dyax Corp. (Nasdaq: DYAX) 44% HIGHER; announced positive topline results from its Phase 3, placebo-controlled trial, EDEMA3, for its lead product candidate DX-88 (ecallantide), for hereditary angioedema (HAE). Statistically significant results were achieved for both the primary and secondary endpoints in the EDEMA3 trial.
Krispy Kreme Doughnuts, Inc. (NYSE: KKD) 5% LOWER; said revenues for the fourth quarter decreased 8.2% to $112.2 million compared to $122.2 million in the fourth quarter of last year. The net loss for the fourth quarter was $24.4 million, or $0.39 per diluted share, compared to a net loss of $37.7 million, or $0.61 per diluted share, in the comparable period last year. The net loss for the quarter includes a charge related to the settlement of litigation of approximately $16.0 million. The Company recorded a $2.1 million provision for doubtful accounts. The Company recorded a $1.3 million charge related to the proposed settlement of certain wage and hour complaints.
Sirius Satellite Radio Inc. (NASDAQ: SIRI) 2.3% HIGHER; XM Satellite Radio (Nasdaq: XMSR) received from the Department of Justice a request for additional information and documentary material relating to our merger with Sirius Satellite.
Merck’s (NYSE: MRK) 1% LOWER; FDA panel votes 20 to 1 against Merck’s Arcoxia pain reliever.
Planar Systems (NASDAQ: PLNR) INDICATED LOWER; expects Q2 sales to be $53-$54 million and Non-GAAP net loss per share to be $0.07 to $0.09. Past guidance was for sales of $57-$61 million and Non-GAAP net income per diluted share of $0.04 to $0.07 and GAAP net loss per share of $0.06 to $0.09.
Shares of Dyax Corp. (Nasdaq: DYAX) 44% HIGHER; announced positive topline results from its Phase 3, placebo-controlled trial, EDEMA3, for its lead product candidate DX-88 (ecallantide), for hereditary angioedema (HAE). Statistically significant results were achieved for both the primary and secondary endpoints in the EDEMA3 trial.
Krispy Kreme Doughnuts, Inc. (NYSE: KKD) 5% LOWER; said revenues for the fourth quarter decreased 8.2% to $112.2 million compared to $122.2 million in the fourth quarter of last year. The net loss for the fourth quarter was $24.4 million, or $0.39 per diluted share, compared to a net loss of $37.7 million, or $0.61 per diluted share, in the comparable period last year. The net loss for the quarter includes a charge related to the settlement of litigation of approximately $16.0 million. The Company recorded a $2.1 million provision for doubtful accounts. The Company recorded a $1.3 million charge related to the proposed settlement of certain wage and hour complaints.
Sirius Satellite Radio Inc. (NASDAQ: SIRI) 2.3% HIGHER; XM Satellite Radio (Nasdaq: XMSR) received from the Department of Justice a request for additional information and documentary material relating to our merger with Sirius Satellite.
Merck’s (NYSE: MRK) 1% LOWER; FDA panel votes 20 to 1 against Merck’s Arcoxia pain reliever.
Planar Systems (NASDAQ: PLNR) INDICATED LOWER; expects Q2 sales to be $53-$54 million and Non-GAAP net loss per share to be $0.07 to $0.09. Past guidance was for sales of $57-$61 million and Non-GAAP net income per diluted share of $0.04 to $0.07 and GAAP net loss per share of $0.06 to $0.09.
Contact [email protected] for any questions or corrections.
Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.
McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.
His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.
A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.
TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.
McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.